lidorestat   Click here for help

GtoPdb Ligand ID: 7411

Synonyms: IDD-000676-01 | IDD-676
PDB Ligand
Compound class: Synthetic organic
Comment: Lidorestat is an experimental aldose reductase inhibitor. [1-2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 83.36
Molecular weight 376.05
XLogP 3.6
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)Cn1cc(c2c1cccc2)Cc1sc2c(n1)c(F)c(cc2F)F
Isomeric SMILES OC(=O)Cn1cc(c2c1cccc2)Cc1sc2c(n1)c(F)c(cc2F)F
InChI InChI=1S/C18H11F3N2O2S/c19-11-6-12(20)18-17(16(11)21)22-14(26-18)5-9-7-23(8-15(24)25)13-4-2-1-3-10(9)13/h1-4,6-7H,5,8H2,(H,24,25)
InChI Key KYHVTMFADJNSGS-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
This compound is being investigated for the treatment of diabetic complications including neuropathy and retinopathy [4].
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Aldose reductase inhibitors decrease the diabetes-associated accumulation of sorbitol in insulin insensitive tissues (such as lense cells, peripheral nerves and the renal glomerulus) which causes damage in these tissues and which leads to diabetic retinopathy, neuropathy and kidney damage [3].